
Ionis Pharmaceuticals IONS
$ 42.94
3.33%
Country |
|
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
160 M |
Market Cap[1] |
$ 6.87 B |
EBITDA (LTM) |
$ -204 M |
P/E (LTM) |
-41.198582 |
P/S (LTM) |
45.71377 |
EPS (LTM) |
-1.41 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX | ||
|
ММЦБ
GEMA
|
- | - | - | MOEX | ||
|
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | ||
|
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | ||
|
Фармсинтез
LIFE
|
- | - | - | MOEX | ||
|
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | ||
|
Промомед
PRMD
|
- | - | - | MOEX | ||
|
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | ||
|
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | ||
|
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market | ||
|
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | ||
|
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | ||
|
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market | ||
|
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | ||
|
Exicure
XCUR
|
$ 1.12 | 0.88 % | $ 7.05 M | Nasdaq Capital Market | ||
|
Cellectis S.A.
CLLS
|
$ 1.04 | 1.36 % | $ 104 M | Nasdaq Global Market | ||
|
AbCellera Biologics
ABCL
|
$ 11.8 | 2.51 % | $ 3.52 B | Nasdaq Global Select Market | ||
|
Arrowhead Pharmaceuticals
ARWR
|
$ 55.9 | 0.22 % | $ 7.48 B | Nasdaq Global Select Market,SPB | ||
|
BioMarin Pharmaceutical
BMRN
|
$ 54.68 | 1.65 % | $ 10.5 B | Nasdaq Global Select Market,SPB | ||
|
Celldex Therapeutics
CLDX
|
$ 27.53 | 3.93 % | $ 1.83 B | Nasdaq Global Select Market | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
$ 3.63 | 0.64 % | $ 44.3 M | Nasdaq Capital Market | ||
|
Jaguar Health
JAGX
|
$ 3.53 | 9.81 % | $ 8.23 M | Nasdaq Capital Market | ||
|
Protalix BioTherapeutics
PLX
|
$ 2.62 | 3.05 % | $ 206 M | NYSE American | ||
|
uniQure N.V.
QURE
|
$ 21.78 | 7.39 % | $ 1.25 B | Nasdaq Global Select Market | ||
|
Stoke Therapeutics
STOK
|
$ 24.17 | 5.8 % | $ 1.43 B | Nasdaq Global Select Market,SPB | ||
|
Xencor
XNCR
|
$ 22.85 | 2.61 % | $ 1.7 B | Nasdaq Global Select Market,SPB | ||
|
Annexon
ANNX
|
$ 3.41 | 1.09 % | $ 529 M | Nasdaq Global Select Market | ||
|
Can-Fite BioPharma Ltd.
CANF
|
$ 1.76 | 0.54 % | $ 2.9 M | NYSE American | ||
|
Incyte Corporation
INCY
|
$ 113.07 | 0.03 % | $ 22.1 B | Nasdaq Global Select Market,SPB | ||
|
Mesoblast Limited
MESO
|
$ 13.28 | 1.16 % | $ 16 B | Nasdaq Global Select Market | ||
|
MeiraGTx Holdings plc
MGTX
|
$ 9.28 | 5.1 % | $ 746 M | Nasdaq Global Select Market | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 499.74 | 0.08 % | $ 128 B | Nasdaq Global Select Market,SPB | ||
|
Ascendis Pharma A/S
ASND
|
$ 225.25 | 0.42 % | $ 13.7 B | Nasdaq Global Select Market | ||
|
Axon Enterprise
AXON
|
$ 390.29 | 2.15 % | $ 30.5 B | Nasdaq Global Select Market,SPB | ||
|
AbbVie
ABBV
|
$ 285.42 | 0.71 % | $ 505 B | NYSE,SPB | ||
|
Black Diamond Therapeutics
BDTX
|
$ 1.72 | 2.35 % | $ 97.8 M | Nasdaq Global Select Market,SPB | ||
|
Altimmune
ALT
|
$ 2.2 | 2.16 % | $ 194 M | Nasdaq Global Market | ||
|
Arbutus Biopharma Corporation
ABUS
|
$ 4.22 | 2.39 % | $ 809 M | Nasdaq Global Select Market | ||
|
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | ||
|
Catalyst Biosciences
CBIO
|
$ 11.84 | 0.87 % | $ 1.06 B | Nasdaq Capital Market | ||
|
Seagen
SGEN
|
- | - | $ 42.2 B | Nasdaq Global Select Market,SPB | ||
|
Codexis
CDXS
|
$ 1.24 | 5.43 % | $ 108 M | Nasdaq Global Select Market | ||
|
Cullinan Management
CGEM
|
$ 12.93 | 2.64 % | $ 779 M | Nasdaq Global Select Market | ||
|
Compugen Ltd.
CGEN
|
$ 1.96 | 4.0 % | $ 183 M | Nasdaq Global Market,SPB | ||
|
Cellectar Biosciences
CLRB
|
$ 1.14 | 0.84 % | $ 2.97 M | Nasdaq Capital Market | ||
|
Amarin Corporation plc
AMRN
|
$ 11.32 | 0.17 % | $ 4.7 B | Nasdaq Global Market | ||
|
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | ||
|
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | ||
|
Cocrystal Pharma
COCP
|
$ 1.02 | 0.49 % | $ 11.5 M | Nasdaq Capital Market | ||
|
Aclaris Therapeutics
ACRS
|
$ 3.28 | 3.25 % | $ 402 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.